MRNA

Moderna, Inc. (MRNA)

Last Price$34.10.9%
Market Cap$13.1B
Relative value
$71.6
Undervalued (Relative Value)
110.2%
NTM P/E
(3.7x)
Peer set median: 11.2x
1Y Fwd EV/EBITDA
(11.5x)
Peer set median: 10.5x
Stock quality
6/10
Good

MRNA Relative Value & Intrinsic Value

Crunching data... Almost there!

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

MRNA Valuation Multiples comparison vs Peer Set

Crunching data... Almost there!

MRNA Valuation multiples overview

Crunching data... Almost there!

MRNA Valuation multiples history vs. Peer set

Crunching data... Almost there!

Explore more intrinsic value tools hub for MRNA

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

What is Moderna, Inc. relative value?

As of Jan 17, 2025, Apple Relative Value is $71.6. This suggests it may be overvalued by 110.2% compared to its current price of around $34.1.

What is Moderna, Inc. DCF (discounted cash flow) valuation?

As of Jan 17, 2025, Moderna, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by N/A to its current price of around $34.1, using a discount rate of 10.5% and terminal growth rate of 3.0%.

What is Moderna, Inc. intrinsic value?

As of Jan 17, 2025, Apple Intrinsic Value is $71.5. This suggests it may be undervalued by 110.0% compared to its current price of around $34.1.